Natalizumab shortage status
1 active shortage notice across 1 country.
Last updated 10 Jul 2026 · sourced from official medicines regulators
- Generic name (INN)
- Natalizumab
- Brand names
- Tyruko
- Class
- Auto-created by Agenzia Italiana del Farmaco — Carenze scraper
Where Natalizumab is in shortage
Why Natalizumab is in shortage
- unexpected increases in demand — e.g. “Elevata richiesta: distribuzione contingentata” (Italy)
Frequently asked questions
Is Natalizumab currently in shortage?
Yes. As of the latest regulator updates, Natalizumab has 1 active shortage notice across 1 country (Italy). Status is refreshed daily from official regulatory sources.
Why is Natalizumab in shortage?
Regulators attribute the current Natalizumab shortages to unexpected increases in demand. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Natalizumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Natalizumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.